amitriptyline has been researched along with fluvoxamine in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.67) | 18.7374 |
| 1990's | 16 (35.56) | 18.2507 |
| 2000's | 14 (31.11) | 29.6817 |
| 2010's | 11 (24.44) | 24.3611 |
| 2020's | 1 (2.22) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anniverno, R; Bellini, L; Gasperini, M; Gatti, F; Smeraldi, E | 1 |
| Mazzi, D; Pallanti, S | 1 |
| Bradshaw, CM; Flett, SR; Szabadi, E | 1 |
| Brockmöller, J; Müller, N; Roots, I | 1 |
| Deanović, Z; Jakovljević, M; Mück-Seler, D | 1 |
| Melzacka, M; Pawłowski, L | 1 |
| Ban, TA; Higano, H; Kelwala, S; Papadatos, Y; Wilson, WH | 1 |
| Bradford, D; Krijzer, F; Snelder, M | 1 |
| Ashford, JJ | 1 |
| Rechlin, T | 1 |
| Bánk, J | 1 |
| Baumann, P; Bertschy, G; Bizouard, P; Bonin, B; Bouquet, S; Francois, T; Sechter, D; Vandel, S | 1 |
| Hashimoto, H; Ikeda, Y; Nakashima, M; Nishimoto, M; Shimazu, Y; Umemura, K | 1 |
| Bakish, D; Cavazzoni, P; Chudzik, J; Hrdina, PD; Lapierre, YD; Ravindran, A | 1 |
| Chover, AJ; Gibert-Rahola, J; Mellado-Fernández, ML; Micó, JA; Ortega-Alvaro, A | 1 |
| Lopukhov, IG | 1 |
| Fundaró, A | 1 |
| Mazo, GE; Razorenov, GI; Razorenova, TS; Vovin, RIa | 1 |
| Bradshaw, CM; Langley, RW; Phillips, MA; Szabadi, E | 1 |
| Bitsios, P; Bradshaw, CM; Phillips, MA; Szabadi, E | 1 |
| Barnett, W; Fritzsche, M; Richter, P; Sattler, HD; von Turner, A | 1 |
| Bailey, P; Castro, JO; Claude, MM; Corrêa, H; Crocq, MA; Diep, TS; Duval, F; Macher, JP; Tremeau, F | 1 |
| Andreĭchik, LA; Granenov, GM; Kostiukova, EG; Mosolov, SN; Serditov, OV | 1 |
| Broda, R; Cangemi, L; Migliaretti, G; Paccotti, P; Portaleone, P; Rosso, C; Rota, E; Torre, E; Zeppegno, P | 1 |
| Amelin, AV; Skoromets, AA; Tarasova, SV | 1 |
| Andersohn, F; Garbe, E; Schade, R; Suissa, S | 1 |
| Miljkovic, B; Pokrajac, M; Prostran, M; Timotijevic, I; Todorovic, Z; Vezmar, S; Vucicevic, K | 1 |
| Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T | 1 |
| Amin, B; Hajhashemi, V | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
4 review(s) available for amitriptyline and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Binding Sites; Cost-Benefit Analysis; Depressive Disorder; Fluvoxamine; Humans; Imipramine; Selective Serotonin Reuptake Inhibitors | 1995 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
14 trial(s) available for amitriptyline and fluvoxamine
| Article | Year |
|---|---|
Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. A double-blind study in depressed inpatients.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Personality Inventory; Recurrence | 1992 |
A comparison of the effects of fluvoxamine and amitriptyline on autonomic functions in healthy volunteers.
Topics: Administration, Oral; Adult; Amitriptyline; Autonomic Nervous System; Blood Pressure; Carbachol; Double-Blind Method; Fluvoxamine; Humans; Male; Pupil; Receptors, Muscarinic; Salivation; Sweat Glands | 1992 |
Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Oximes; Psychiatric Status Rating Scales; Serotonin; Trazodone | 1991 |
A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Autonomic Nervous System; Blood Pressure; Double-Blind Method; Doxepin; Drug Evaluation; Female; Fluvoxamine; Humans; Male; Oximes; Pulse; Pupil; Salivation; Time Factors | 1983 |
The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Drug Administration Schedule; Electrocardiography; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Paroxetine | 1994 |
A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.
Topics: Adult; Amitriptyline; Female; Fluvoxamine; Humans; Male; Middle Aged; Migraine Disorders | 1994 |
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
Topics: Adult; Amitriptyline; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype | 1995 |
The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antidepressive Agents; Arousal; Attention; Blinking; Cross-Over Studies; Double-Blind Method; Electroencephalography; Electromyography; Evoked Potentials, Auditory; Fluvoxamine; Humans; Male; Morpholines; Neural Inhibition; Reaction Time; Reboxetine; Reflex, Startle | 2000 |
Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Anxiety; Cross-Over Studies; Double-Blind Method; Fluvoxamine; Happiness; Humans; Male; Morpholines; Psychiatric Status Rating Scales; Pupil; Reboxetine; Wakefulness | 2000 |
Neurophysiologic tests during antidepressive treatment - an exploratory study.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Autonomic Nervous System; Depressive Disorder, Major; Doxepin; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Neural Conduction; Paroxetine; Psychometrics; Reaction Time; Reflex; Selective Serotonin Reuptake Inhibitors | 2000 |
Noradrenergic dysfunction and antidepressant treatment response.
Topics: Adrenergic alpha-Agonists; Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clonidine; Depressive Disorder; Female; Fluvoxamine; Human Growth Hormone; Humans; Male; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Radioimmunoassay | 2001 |
[Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital].
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Tolerance; Female; Fluvoxamine; Hospitalization; Hospitals, Psychiatric; Humans; International Classification of Diseases; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors | 2003 |
[Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache].
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Chronic Disease; Electric Stimulation Therapy; Female; Fluvoxamine; Headache; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Skull | 2008 |
Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Fluvoxamine; Half-Life; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 2009 |
27 other study(ies) available for amitriptyline and fluvoxamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
MDMA (Ecstasy) precipitation of panic disorder.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Agoraphobia; Alcohol Drinking; Amitriptyline; Arousal; Fluvoxamine; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic Disorder; Recurrence; Substance Withdrawal Syndrome; Tranylcypromine | 1992 |
Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele--a slowly reversible interaction with fluoxetine.
Topics: Alleles; Amitriptyline; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Debrisoquin; Depression; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Half-Life; Humans; Middle Aged; Nortriptyline; Phenotype; Spectrophotometry, Ultraviolet | 1991 |
Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Brain; Chromatography, Gas; Citalopram; Fluvoxamine; Male; Oximes; Propylamines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1986 |
Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.
Topics: Amitriptyline; Animals; Antidepressive Agents; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Fluvoxamine; Imipramine; Male; Maprotiline; Mianserin; Oximes; Rats; Rats, Inbred Strains; Seizures; Viloxazine | 1984 |
Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Dogs; Electrocardiography; Evoked Potentials; Fluvoxamine; Heart; Myocardial Infarction; Propranolol | 1996 |
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Platelets; Carrier Proteins; Depressive Disorder; Doxepin; Female; Fluvoxamine; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Receptor, Serotonin, 5-HT2A; Receptors, Drug; Receptors, Serotonin; Serotonin; Trazodone; Treatment Outcome | 1997 |
The effects of different monoaminergic antidepressants on the analgesia induced by spinal cord adrenal medullary transplants in the formalin test in rats.
Topics: Adrenal Medulla; Amitriptyline; Analgesia; Animals; Antidepressive Agents; Desipramine; Fluvoxamine; Formaldehyde; Male; Rats; Rats, Wistar; Spinal Cord | 1997 |
[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Evaluation; Female; Fluoxetine; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Time Factors | 1997 |
Pinch-induced catalepsy in mice: a useful model to investigate antidepressant or anxiolytic drugs.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Catalepsy; Female; Fluoxetine; Fluvoxamine; Imipramine; Learning; Male; Mice; Models, Psychological; Motor Activity; Ondansetron; Physical Stimulation; Reaction Time; Serotonin Antagonists; Sex Characteristics; Stereotyped Behavior | 1998 |
[Choice of therapeutic tactics in treatment of endogenous depression by means of statusmetric expert system].
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
Milnacipran: new preparation. Tricyclics remain first-line antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclopropanes; Drug Evaluation; Europe; Fluoxetine; Fluvoxamine; Humans; Imipramine; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States | 1998 |
Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Amitriptyline; Circadian Rhythm; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluvoxamine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2005 |
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride | 2009 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger | 2009 |
Effect of glibenclamide on antinociceptive effects of antidepressants of different classes.
Topics: Amitriptyline; Analgesics; Analysis of Variance; Animals; Antidepressive Agents; Drug Interactions; Fluvoxamine; Glyburide; Male; Maprotiline; Mice; Models, Animal; Pain; Pain Measurement; Potassium Channel Blockers; Potassium Channels; Random Allocation | 2011 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |